Posts

Unnamed Pharma Files Citizen Petition Urging FDA to Reform CRL Disclosure Practices

An unnamed pharmaceutical company filed a citizen petition on April 20, 2026, calling for the FDA to reform its policy of publicly releasing complete response letters (CRLs), deeming it unlawful and contrary to decades of practice. 2 3 The petition demands a clear process where FDA notifies manufacturers before releasing CRLs, allows 10 days to contest publication, and provides written reasoning if proceeding despite objections. 2 3 It raises intellectual property concerns, arguing that released CRLs contain competitively sensitive information that federal law requires protecting, and calls for sponsor input on redactions. 2 4 FDA began publishing over 200 redacted CRLs in July 2025 as part of its 'radical transparency' initiative, now expanded to more than 300, accessible on its website. 1 2 The policy has increased biopharma accountability by making companies more forthcoming about rejection details, though redactions and private meeting minutes limit full transparenc...

Merck's AI Partnership with Google Cloud to Reimagine Commercial Engagement with HCPs

Roche's Oral SERD Giredestrant Shows Mixed Clinical Results but Remains Strategically Important

Regeneron Among Remaining Holdouts in Trump's Most-Favored-Nation Drug Pricing Deals

Live Friday: CDC Ends Universal COVID-19 Vaccine Recommendation – Anti-Vax Shift Under RFK Jr.?

BBOT Shakes Up Leadership as RAS Competitors Gain Visibility

Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer

Nektar Therapeutics Prices Upsized $325M Public Offering Amid Biotech News

AbbVie's $1.4 Billion North Carolina Manufacturing Campus Announcement

Sanofi Defends Belén Garijo's CEO Appointment Amid R&D and Immunology Focus

Labcorp Launches FDA-Approved Companion Diagnostic for KEYTRUDA in Platinum-Resistant Ovarian Cancer

Samsung Biologics Achieves Record Revenue Amid Union Strike Threat

Eli Lilly Terminates Rigel Pharmaceuticals RIPK1 Inhibitor Collaboration Effective June 15, 2026